Parties d'ouvrages collectifs (5)
Articles dans des revues avec comité de lecture (425)
1.
Suleiman, M., Sawatani, T., Tesi, M., Yi, X., Papadopoulou, T., Rufer, C., Lytrivi, M., Bosi, E., Burdet, F., Fantuzzi, F., De Luca, C., Sebastiani, G., Saponaro, C., Pugliese, L. A., Del Guerra, S., Pocai, A., De Simone, P., Ghinolfi, D., Boggi, U., Kessler, C., Grieco, G. E., Fignani, D., Kerr-Conte, J., Pattou, F., Nacher, M., Montanya, E., Mourad, N. N., Buemi, A., Citi, V., Martelli, A., Benedetti, G., Calderone, V., Rossi, L., Paolicchi, A., Cardarelli, F., Dotta, F., Eizirik, D. L., Ibberson, M., Marchetti, P., Cnop, M., & Marselli, L. (2025). Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches. Science advances, 11(41), eads2905. doi:10.1126/sciadv.ads29052.
Piron, A., Szymczak, F., Folon, L., Crouch, D. J. M., Papadopoulou, T., Lytrivi, M., Tong, Y., Alvelos, M. I., Colli, M. L., Yi, X., Pekalski, M. M., Hatzikotoulas, K., Huerta-Chagoya, A., Taylor, H. J., Type 2 Diabetes Global Genomics Initiative,, Defrance, M., Todd, J. A., Eizirik, D. L., Mercader, J. M., & Cnop, M. (2025). Identification of novel type 1 and type 2 diabetes genes by co-localization of human islet eQTL and GWAS variants with colocRedRibbon. Cell Genomics, 101004. doi:10.1016/j.xgen.2025.1010043.
Yi, X., Zimath, P. L., Martin-Vazquez, E., Garcia De Oliveira, J., Jawurek, S., Title, A. C., Yesildag, B., Mourad, N. I., Buemi, A., Pattou, F., Kerr-Conte, J., Costagliola, S., Romitti, M., & Eizirik, D. L. (2025). Transcriptomics of autoimmune diseases identifies FGFR1 as a target for pancreatic β-cell protection. Journal of autoimmunity, 156, 103469. doi:10.1016/j.jaut.2025.1034694.
Costa Junior, J. M., Coomans De Brachene, A., Musuaya, A., Zimath, P. L., Martin Vázquez, E., Oliveira, J. G., Carpentier, J., Faoro, V., Klass, M., Cnop, M., & Eizirik, D. L. (2025). Exercise-induced meteorin-like protein protects human pancreatic beta cells from cytokine-induced apoptosis. Diabetologia, 68(7), 1524-1529. doi:10.1007/s00125-025-06426-26.
Robertson, C. C., Elgamal, R. R., Henry-Kanarek, B. B., Arvan, P., Chen, S., Dhawan, S., Eizirik, D. L., Kaddis, J. J., Vahedi, G., Parker, S. G., Gaulton, K. K., & Soleimanpour, S. S. (2024). Untangling the genetics of beta cell dysfunction and death in type 1 diabetes. Molecular metabolism, 86, 101973. doi:10.1016/j.molmet.2024.1019737.
Muralidharan, C., Huang, F., Enriquez, J. J., Wang, J. J., Nelson, J. J., Nargis, T., May, S. S., Chakraborty, A., Figatner, K. K., Navitskaya, S., Anderson, C. C., Calvo, V., Surguladze, D., Mulvihill, M. M., Yi, X., Sarkar, S., Oakes, S. S., Webb-Robertson, B.-J. M., Sims, E. E., Staschke, K. K., Eizirik, D. L., Nakayasu, E. S., Stokes, M. M., Tersey, S. S., & Mirmira, R. R. (2024). Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice. The Journal of clinical investigation, 134(12). doi:10.1172/JCI176136